WHO Ebola vaccine funding review raises questions over $60M platform expansion tied to COVID-era systems

WHO Ebola vaccine funding review shown in investigative newsroom scene with analysts reviewing Ebola vaccine funding and COVID-era vaccine platform data panels

A WHO Ebola vaccine funding review has sparked debate over $60 million in expanded vaccine development using COVID-era platforms. Critics question transparency, while officials emphasize rapid outbreak readiness.

Trump Strikes Back: The End of Billions to Gates’ Vaccine Empire

A silent war has been raging beneath the surface, a battle not fought with weapons, but with control. For decades, shadowy figures have pulled the strings, siphoning taxpayer money into the veins of globalist institutions masquerading as humanitarian efforts. Now, the tide is turning. President Donald J. Trump has done what many feared—and what even … Read more